CRSR heads into its August 6 earnings release with a notable gap between a surging stock price and a Street that has only just started catching up.
The clearest signal this week is analyst momentum. Wedbush raised its price target from $8 to $13 on August 3, maintaining its Outperform rating — a 62% target lift that still trails a stock now trading at $11.37, up 28% over the past month. Roth Capital initiated coverage on July 22 with a Buy and a $15 target, the most bullish stance on the Street. B. Riley lifted its target to $9 from $7.50 while holding Neutral. The direction of travel is unambiguously upward, yet the consensus mean price target of $10.22 still sits below the current price — meaning the Street collectively has not yet caught up with a stock that has more than doubled year-to-date. That gap is the central tension heading into tonight's print.
Short positioning tells a more cautious story beneath the surface. Short interest holds at around 10.7% of the free float — a genuinely elevated level — and has edged up roughly 0.6% over the past week, with roughly 11.4 million shares short. Yet the borrow market shows no signs of stress. Availability is running at 244%, meaning there are more than two shares available to borrow for every one already shorted, and well within the normal range. Cost to borrow has actually eased over the past month, falling 26% to just 0.37% — near its cheapest level of the period. Short sellers are present in size but they are not squeezed, and new shorts face no meaningful friction in adding exposure.
Options positioning has shifted decisively toward calls. The put/call ratio has dropped to 0.26, roughly one standard deviation below its 20-day average of 0.31, and sits near the lower end of its one-year range — the 52-week low is 0.034 and the high was 0.61. Investors are leaning into upside rather than hedging. That call-heavy tilt aligns with the stock's recent momentum and the fresh analyst upgrades, but it also means expectations into earnings are running warm rather than cautious.
The bull-bear debate on CRSR is well-defined. Bulls point to Q4 2025's 12.3% adjusted EBITDA margin beat, an AI workstation and server push as a new growth vector, and the Fanatec integration adding to the peripherals mix. Bears flag a controlled-company structure with EagleTree Capital holding 52.7% of shares, concentration risk from the top-10 customers, and a memory business that has faced persistent headwinds. Valuation multiples have moved materially — the P/E ratio has expanded by roughly 2.2 points over the past 30 days and price-to-book is up 0.25 in the same window, reflecting the stock's sharp re-rating. The analyst recommendation divergence factor scores in the 93rd percentile, meaning CRSR sits near the top of the universe for dispersion between bulls and bears — reinforcing that this is a genuinely contested name.
Recent earnings history offers limited precision: the last comparable print on May 7 produced an 8.5% one-day gain. The previous event in June moved just 0.5% on the day. The pattern is inconsistent, which makes the call-heavy options positioning a meaningful read on directional sentiment rather than a mechanical positioning signal.
What to watch: whether tonight's Q2 results — particularly progress on the Fanatec integration and any update on the AI workstation pipeline — are enough to finally pull analyst consensus targets above the current share price and resolve the gap that has defined this stock's setup all week.
See the live data behind this article on ORTEX.
Open CRSR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
